National Research Council Canada · Contribution program
Biologics Manufacturing Centre
Canada's contribution to maintain and operate the BMC facility in a constant Good Manufacturing Practice (GMP)-readiness state to respond to pandemic and other health emergencies, ensuring surety of domestic vaccines and other biologics for Canadians.
- Total value
- $173M
- Agreements
- 1
- Dec 2022 to Dec 2022
- Median agreement
- $173M
- Typical range
- $173M–$173M
- the middle half of agreements
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026.
See every record for this program on the government’s search. How to apply: look up the program on National Research Council Canada’s website.
Who got it
Organizations with the most funding under this program.
| Recipient | Agreements | Total |
|---|---|---|
| Biologics Manufacturing Centre (Bmc) Inc. | 1 | $173M |
By year
Agreements by the year they started.
| Year | Agreements | Total |
|---|---|---|
| 2022 | 1 | $173M |
By province
| Province or territory | Agreements | Total |
|---|---|---|
| Quebec | 1 | $173M |
By type of recipient
As the department classified the recipient.
| Recipient type | Agreements | Total |
|---|---|---|
| Not-for-profit organizations and charities | 1 | $173M |
Latest agreements
| Start | Recipient | What for | Value |
|---|---|---|---|
| Dec 2022 | Biologics Manufacturing Centre (Bmc) Inc. | Contribution towards the opearation of BMC incContribution | $172,791,000 |